Andrew Holden spoke to Vascular News at LINC 2018 (Leipzig Interventional Course; 30 January–2 February, Leipzig, Germany) about the new data from the IN.PACT AV access trial and its significance, as well as Holden’s experience with the drug-coated balloon at his New Zealand centre.
Outstanding work by Professor Holden and team at Auckland Hospital New Zealand